Search

Your search keyword '"Joel Simrén"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Joel Simrén" Remove constraint Author: "Joel Simrén" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
27 results on '"Joel Simrén"'

Search Results

1. Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19

2. Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor–induced CNS inflammationResearch in context

3. CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals

4. Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease

5. Combining impact monitoring mouthguards and blood biomarkers to monitor head impacts among Muay Thai athletes – A case study

6. Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability

7. Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg

8. Early plasma biomarker dynamic profiles are associated with acute ischemic stroke outcomes

9. Protein tau concentration in blood increases after SCUBA diving: an observational study

12. Assessing the clinical application of deep-learning-derived CT volumetric measures in neurodegenerative disease diagnostics

13. Diagnostic value of serum versus plasma phospho‐tau for Alzheimer’s disease

15. Neuropathological validation of plasma GFAP

17. Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19

18. Post-acute blood biomarkers and disease progression in traumatic brain injury

19. Reply to Dr. Arieli regarding our article protein tau concentration in blood increases after SCUBA diving: an observational study published in European journal of applied physiology 2022;122:993-1005

21. Long noncoding RNA MEG3 activates neuronal necroptosis in Alzheimer’s disease

22. Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years

23. Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults

24. Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community‐based sample of 70‐year‐olds

25. Plasma and cerebrospinal fluid neurofilament light protein concentrations are differentially associated with biomarker evidence of neurodegeneration in a community‐based population of 70‐year‐olds

27. Neurochemical signs of astrocytic and neuronal injury in acute COVID‐19 normalizes during long‐term follow‐up

Catalog

Books, media, physical & digital resources